Guangzhou Wondfo Biotech Co., Ltd. (SZ300482, hereinafter referred as Wondfo) has been “devoted to the main battlefield of national economy with scientific and technological strength” since 1992. Adhering to the mission of "Racing for Life", we always firmly believe that "innovation is the soul" and continue to accelerate the improvement of scientific and technological innovation strength. Currently, Wondfo has been approved as National Postdoctoral Research Workstation, State-Level Corporate Technology Center and National Intellectual Property Demonstration Enterprise. In the field of in vitro diagnosis under the medical device segment, Wondfo has been a leading company in China focusing on the R&D, manufacturing, sales and service of Point-of-Care Testing reagents and instruments. Our products have been widely distributed to over 140 countries and regions and applied for clinical testing, measurement of critical and acute diseases, chronic disease management, primary healthcare, pandemic monitoring, disaster relief, on-site DOA testing for law enforcement, individual & family health management, etc. Based on disease-targeted layout of products and technologies constantly improved, we strive to make domestic and overseas markets mutual beneficial, with domestic market as the majority, so as to achieve the goal to lead the global IVD industry.
Instruments
Reagents
Here is an opportunlty to contact and meet other potentlal companles or partners.
If you are interested in booking a stand at CACLP, please leave your details below and one of our representatives will be in touch soon.
Copyright © 2024 GL events Ruihe (Shanghai) Exhibition Co., Ltd. All Rights Reserved. ( 沪ICP备12004745号-1 )
We deliver the latest IVD news straight to your inbox. Stay in touch with CACLP News.
sign-up for our newsletter today.
To ensure our newsletter hit your inbox, make sure to add @caclp.com to your safe senders list. And, as always, feel free to contact
us with any questions and thanks again for subscribing.
Go back
